Request Demo
Last update 23 Aug 2025
Teriparatide Acetate( Asahi Kasei Pharma)
Last update 23 Aug 2025
Overview
Basic Info
Drug Type Synthetic peptide |
Synonyms Teriparatide Acetate, MN-10-T, Teribone + [1] |
Target |
Action agonists |
Mechanism PTH1R agonists(Parathyroid hormone receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (26 Sep 2011), |
Regulation- |
Login to view timeline
Structure/Sequence
Sequence Code 4953
Source: *****
Related
3
Clinical Trials associated with Teriparatide Acetate( Asahi Kasei Pharma)KCT0004153
A randomized, open-label, single dose, 2-sequence, 2-period crossover study to explore the safety and pharmacokinetic characteristics of Teribone injection 56.5ug and Rap18001 in postmenopausal female volunteers
JPRN-jRCT2080223422
Phase III clinical study of MN-10-T AI for patients with osteoporosis at higher fracture risk
JPRN-UMIN000022345
A study on the effect of teriparatide acetate injections in the rotator cuff tear repair. - A study on the effects of teriparatide in the ARCR.
100 Clinical Results associated with Teriparatide Acetate( Asahi Kasei Pharma)
Login to view more data
100 Translational Medicine associated with Teriparatide Acetate( Asahi Kasei Pharma)
Login to view more data
100 Patents (Medical) associated with Teriparatide Acetate( Asahi Kasei Pharma)
Login to view more data
100 Deals associated with Teriparatide Acetate( Asahi Kasei Pharma)
Login to view more data
R&D Status
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Osteoporosis | Japan | 26 Sep 2011 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free